DR. MATTHEW J. DOLAN, M.D.
Osteopathic Medicine in San Antonio, TX
License number
Texas 59493
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2200 Bergquist Dr Ste 1 Attn: Credentials (Cmc) STE 1, San Antonio, TX 78236
Phone
(210) 292-7444
(210) 679-7306
(210) 679-7306
Professional information
Dr. Matthew J Dolan, San Antonio TX - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
3551 Roger Brooke Dr, San Antonio 78234
2200 Bergquist Dr STE 1, San Antonio 78236
(210) 292-7444 (Phone)
2200 Bergquist Dr STE 1, San Antonio 78236
(210) 292-7444 (Phone)
Certifications:
Infectious Disease, 1992, Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Dartmouth College
Graduated: 1985
University of Medicine And Dentistry of New Jersey / Robert Wood Johnson Medical School
Graduated: 2013
Wilford Hall Usaf Med Center
Dartmouth College
Graduated: 1985
University of Medicine And Dentistry of New Jersey / Robert Wood Johnson Medical School
Graduated: 2013
Wilford Hall Usaf Med Center
Matthew James Dolan, Lackland A F B TX
Specialties:
Infectious Disease Specialist
Address:
2200 Bergquist Dr, Lackland A F B, TX 78236
3851 Roger Brooke Dr, Fort Sam Houston, TX 78234
3851 Roger Brooke Dr, Fort Sam Houston, TX 78234
Education:
Dartmouth College, Medical School - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Screening For Disease Susceptibility By Genotyping The Ccr5 And Ccr2 Genes
US Patent:
2010002, Jan 28, 2010
Filed:
Jun 13, 2008
Appl. No.:
12/157956
Inventors:
Sunil Ahuja - San Antonio TX, US
Enrique Gonzales - San Antonio TX, US
Srinivas Mummidi - San Antonio TX, US
Matthew J. Dolan - San Antonio TX, US
Mike Bamshad - Salt Lake City UT, US
Enrique Gonzales - San Antonio TX, US
Srinivas Mummidi - San Antonio TX, US
Matthew J. Dolan - San Antonio TX, US
Mike Bamshad - Salt Lake City UT, US
International Classification:
C12Q 1/68, C07H 21/04
US Classification:
435 6, 536 2431
Abstract:
Provided are compositions, methods and uses for identifying persons at an increased risk of infection by, transmission of, or accelerated progression of a disease caused by an HIV-1 virus. Diagnostic, prognostic and combined therapeutic kits are also provided.
Methods And Compositions For Correlating Ccl3L1/Ccr5 Genotypes With Disorders
US Patent:
2008031, Dec 18, 2008
Filed:
Jul 6, 2005
Appl. No.:
11/791403
Inventors:
Sunil K. Ahuja - San Antonio TX, US
Matthew Dolan - San Antonio TX, US
Hemant Kulkarni - San Antonio TX, US
Enrique Gonzalez - San Antonio TX, US
Matthew Dolan - San Antonio TX, US
Hemant Kulkarni - San Antonio TX, US
Enrique Gonzalez - San Antonio TX, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides compositions and methods for identifying persons at an increased risk of infection by, transmission of, or accelerated progression of a disease caused by an HIV-1 virus. Diagnostic and therapeutic kits are also provided.
Screening For Disease Susceptibility By Genotyping The Ccr5 And Ccr2 Genes
US Patent:
7393634, Jul 1, 2008
Filed:
Oct 12, 2000
Appl. No.:
10/089595
Inventors:
Sunil Ahuja - San Antonio TX, US
Enrique Gonzales - San Antonio TX, US
Srinivas Mummidi - San Antonio TX, US
Matthew J. Dolan - San Antonio TX, US
Mike Bamshad - Salt Lake City UT, US
Enrique Gonzales - San Antonio TX, US
Srinivas Mummidi - San Antonio TX, US
Matthew J. Dolan - San Antonio TX, US
Mike Bamshad - Salt Lake City UT, US
Assignee:
United States of America as represented by the Secretary of the Air Force - Washington DC
The University of Texas System, Board of Regents - Austin TX
The University of Utah Research Foundation - Salt Lake City UT
The University of Texas System, Board of Regents - Austin TX
The University of Utah Research Foundation - Salt Lake City UT
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/02, C07H 21/04
US Classification:
435 6, 435 911, 435 912, 536 231, 536 243
Abstract:
Provided are compositions, methods and uses for identifying persons at an increased risk of infection by, transmission of, or accelerated progression of a disease caused by an HIV-1 virus. Diagnostic, prognostic and combined therapeutic kits are also provided.